VERIFIEDMint Companies·31 Jul 2026neutral

Sun Pharma misses Q1 estimates as US generics drag offsets India growth

AI Summary

·Sun Pharma's revenue and profit increased in double digits during the June quarter.
·Softer US generics sales impacted the company's performance.
·Margin pressure was also a contributing factor to missing expectations.